IP Library Granted Patent US 9,585,937
Granted Patent B2
US 9,585,937 · App. 14/963,575 · Granted Mar 7, 2017

Method and kit for bowel preparation

Inventors: Steven Gorelick (Danbury, CT); Michael Schiffman (Weston, CT); Melody Olmstead (New Milford, CT); Adam Gorelick (Woodbridge, CT)
Assignee: MSM Innovations, Inc.
A61K38/168A61K9/0095A61K36/185A61K47/10A61K47/12A61K47/34A61K47/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,937
App. No.
14/963,575
Granted
Mar 7, 2017
Kind
B2
Abstract

The present invention provides methods and taste-modifying kits for facilitating cleansing of the gastrointestinal tract of a patient prior to a diagnostic, surgical or therapeutic procedure. The methods and taste-modifying kits can improve patient compliance, and thus, efficacy of the preparation. Specifically, the present methods make the gastrointestinal tract preparation composition palatable for the patient to consume. For example, for a patient preparing to undergo colonoscopy, the present methods make the bowel preparation solution taste significantly less salty.

Claims (17)

1. A taste-modifying kit for facilitating cleansing the gastrointestinal tract of a subject comprising: a gastrointestinal tract preparation composition having a salty taste, a premeasured amount of at least one pH-modifying agent wherein the amount is sufficient to adjust the pH of the gastrointestinal tract preparation composition to a pH ranging from 1 to 6.9, miraculin, and instruction material indicating that the gastrointestinal tract of the subject is to be cleansed by a method comprising the steps of:

(a) determining the pH of the gastrointestinal tract preparation composition, wherein the pH ranges from 1 to 6.9 or is adjusted to range from 1 to 6.9 using the at least one pH-modifying agent;

(b) providing miraculin to the subject; and

(c) administering orally the gastrointestinal tract preparation composition or a diluted form of the gastrointestinal tract preparation composition to the subject after step (b).

2. The kit of claim 1 , wherein the pH-modifying agent is an acid selected from the group consisting of citric acid, acetic acid and ascorbic acid, phosphoric acid, malic acid, succinic acid, formic acid, fumaric acid, maleic acid, adipic acid, butyric acid, glyconic acid, lactic acid, oxalic acid, tartaric acid and mixtures thereof.

3. The kit of claim 1 , wherein the pH-modifying agent is selected from the group consisting of ammonium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, carbon dioxide, and mixtures thereof.

4. The kit of claim 1 , wherein miraculin comprises miracle fruit, flesh of miracle fruit, miracle fruit granules, miracle berry, miracle berry extracts, miracle fruit tablets, miracle berry tablets, or miraculin produced by a genetically modified organism.

5. The kit of claim 1 , wherein the premeasured amount of the pH-modifying agent is sufficient to adjust the pH of the gastrointestinal tract preparation solution to a pH ranging from 3 to 6.4.

6. The kit of claim 1 , wherein miraculin is provided to the subject from 1 minute to 1 hour before the gastrointestinal tract preparation composition is administered.

7. The kit of claim 6 , wherein miraculin is provided from 5 minutes to 30 minutes before the gastrointestinal tract preparation composition is administered.

8. The kit of claim 1 , wherein the gastrointestinal tract preparation composition has a salty taste, and wherein the salty taste is reduced by at least 20% compared to the salty taste of the gastrointestinal tract preparation composition had miraculin not been provided.

9. The kit of claim 1 , wherein the gastrointestinal tract is the intestine and the gastrointestinal tract preparation composition is a bowel preparation solution.

10. The kit of claim 9 , wherein the intestine is the colon.

11. The kit of claim 1 , wherein the gastrointestinal tract is cleansed prior to carrying out a diagnostic, therapeutic and/or surgical procedure on the patient.

12. The kit of claim 1 , wherein the gastrointestinal tract is cleansed prior to an endoscopy.

13. The kit of claim 12 , wherein the endoscopy is a colonoscopy or sigmoidoscopy.

14. The kit of claim 1 , wherein the gastrointestinal tract is cleansed prior to a barium enema examination, capsule endoscopy, virtual colonoscopy, colon surgery or gastrointestinal tract surgery.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2015
From: GORELICK, STEVEN; SCHIFFMAN, MICHAEL; OLMSTEAD, MELODY; GORELICK, ADAM
To: MSM INNOVATIONS, INC.
Reel/Frame 037249/0162 →
Continuity (5)
Continuation 13957857 · Aug 2, 2013
Continuation In Part 13708430 · Dec 7, 2012
Provisional Application 61679183 · Aug 3, 2012
Provisional Application 61568131 · Dec 7, 2011
Related Publication 20160089331A1 · Mar 31, 2016